Lonza to buy U.S. capsule maker Capsugel for $5.5 billion
(Reuters) - Swiss pharmaceutical manufacturer Lonza Group AG said on Thursday it is buying Capsugel, a U.S. maker of capsule products and other drug delivery systems, for $5.5 billion in cash.
No comments:
Post a Comment